TY - JOUR
T1 - The function of (Na+K+)ATPase in the β cell
T2 - Characterization of the enzyme in a glucose-responsive insulinoma
AU - Hoenig, Margarethe
N1 - Funding Information:
Supported by First Award DK-41869.
PY - 1992/8
Y1 - 1992/8
N2 - (Na+K+)ATPase is necessary for the maintenance of the membrane potential. The activity of this enzyme was studied in purified plasma membranes from a glucose-responsive rat insulinoma. Ouabain-sensitive (Na+K+)ATPase activity showed expected ATP dependency with a Km of 0.4 mm. It was also dependent on Mg2+ (Km range 70-80 μM). In the presence of Mg and ATP, half-maximal activity was obtained at a Na concentration of 30 mm and the enzyme activity increased sigmoidally with a Hill coefficient of 1.5. No direct effect on enzyme activity was observed with the insulin secretagogues glucose, fructose, glyceraldehyde, and ketoisocaproate, or with dibuturyl-cAMP and the phosphodiesterase-inhibitor isobutyl methyl xanthine. It is concluded that (Na+K+)ATPase is not directly influenced by known secretagogues associated with insulin release by the β cell.
AB - (Na+K+)ATPase is necessary for the maintenance of the membrane potential. The activity of this enzyme was studied in purified plasma membranes from a glucose-responsive rat insulinoma. Ouabain-sensitive (Na+K+)ATPase activity showed expected ATP dependency with a Km of 0.4 mm. It was also dependent on Mg2+ (Km range 70-80 μM). In the presence of Mg and ATP, half-maximal activity was obtained at a Na concentration of 30 mm and the enzyme activity increased sigmoidally with a Hill coefficient of 1.5. No direct effect on enzyme activity was observed with the insulin secretagogues glucose, fructose, glyceraldehyde, and ketoisocaproate, or with dibuturyl-cAMP and the phosphodiesterase-inhibitor isobutyl methyl xanthine. It is concluded that (Na+K+)ATPase is not directly influenced by known secretagogues associated with insulin release by the β cell.
UR - http://www.scopus.com/inward/record.url?scp=0026646730&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026646730&partnerID=8YFLogxK
U2 - 10.1016/0885-4505(92)90052-Z
DO - 10.1016/0885-4505(92)90052-Z
M3 - Article
C2 - 1326302
AN - SCOPUS:0026646730
SN - 0885-4505
VL - 48
SP - 81
EP - 85
JO - Biochemical Medicine and Metabolic Biology
JF - Biochemical Medicine and Metabolic Biology
IS - 1
ER -